 | • レポートコード：QAF27712 • 出版社/出版日：QYResearch / 2021年4月6日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の肝細胞増殖因子市場について種類別（フェーズIII（進行中）、フェーズII（承認済み）、フェーズII（進行中）、フェーズ1、前臨床）、用途別（腫瘍学、心血管系、中枢神経系、造血系疾患、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・肝細胞増殖因子市場の概要 ・世界の主要地域別肝細胞増殖因子市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の肝細胞増殖因子市場規模2016-2021：種類別（フェーズIII（進行中）、フェーズII（承認済み）、フェーズII（進行中）、フェーズ1、前臨床） ・世界の肝細胞増殖因子市場予測2012-2027：種類別（フェーズIII（進行中）、フェーズII（承認済み）、フェーズII（進行中）、フェーズ1、前臨床） ・世界の肝細胞増殖因子市場規模2016-2021：用途別（腫瘍学、心血管系、中枢神経系、造血系疾患、その他） ・世界の肝細胞増殖因子市場予測2012-2027：用途別（腫瘍学、心血管系、中枢神経系、造血系疾患、その他） ・肝細胞増殖因子のアメリカ市場規模と予測2016-2021 ・肝細胞増殖因子のヨーロッパ市場規模と予測2016-2021 ・肝細胞増殖因子の中国市場規模と予測2016-2021 ・肝細胞増殖因子の日本市場規模と予測2016-2021 ・肝細胞増殖因子の東南アジア市場規模と予測2016-2021 ・肝細胞増殖因子のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （ViroMed、AnGes MG、M3 Biotechnology、AVEO Pharmaceuticals、Molecular Partners、Yooyoung Pharm、F-star、Galaxy Biotech、Kringle Pharma） ・肝細胞増殖因子の製造コスト分析 ・販売チャネル、流通業者、顧客 ・肝細胞増殖因子の市場動向・機会・課題 ・調査の結論 |
Hepatocyte growth factor (HGF) (or scatter factor (SF) is a paracrine cellular growth, motility and morphogenic factor. It is secreted by mesenchymal cells and targets and acts primarily upon epithelial cells and endothelial cells, but also acts on haemopoietic progenitor cells and T cells. It has been shown to have a major role in embryonic organ development, specifically in myogenesis, in adult organ regeneration, and in wound healing.
The application of hepatocyte growth factor includes oncology, cardiovascular, central nervous system, hematological disorders and others, and the proportion of R&D Investment for oncology in 2017 is about 36%, and the proportion is in decreasing trend from 2012 to 2016.
Market Analysis and Insights: Global Hepatocyte Growth Factor Market
The global Hepatocyte Growth Factor market was valued at US$ 53 in 2020 and will reach US$ 74 million by the end of 2027, growing at a CAGR of 5.7% during 2022-2027.
Global Hepatocyte Growth Factor Scope and Market Size
The global Hepatocyte Growth Factor market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hepatocyte Growth Factor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Phase III (Ongoing)
Phase II (Approved)
Phase II (Ongoing)
Phase 1
Preclinical
Segment by Application
Oncology
Cardiovascular
Central Nervous System
Hematological Disorders
Others
The Hepatocyte Growth Factor market is analysed and market size information is provided by regions (countries). Segment by Application, the Hepatocyte Growth Factor market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
ViroMed
AnGes MG
M3 Biotechnology
AVEO Pharmaceuticals
Molecular Partners
Yooyoung Pharm
F-star
Galaxy Biotech
Kringle Pharma
1 Hepatocyte Growth Factor Market Overview
1.1 Hepatocyte Growth Factor Product Scope
1.2 Hepatocyte Growth Factor Segment by Type
1.2.1 Global Hepatocyte Growth Factor Sales by Type (2016 & 2021 & 2027)
1.2.2 Phase III (Ongoing)
1.2.3 Phase II (Approved)
1.2.4 Phase II (Ongoing)
1.2.5 Phase 1
1.2.6 Preclinical
1.3 Hepatocyte Growth Factor Segment by Application
1.3.1 Global Hepatocyte Growth Factor Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Oncology
1.3.3 Cardiovascular
1.3.4 Central Nervous System
1.3.5 Hematological Disorders
1.3.6 Others
1.4 Hepatocyte Growth Factor Market Estimates and Forecasts (2016-2027)
1.4.1 Global Hepatocyte Growth Factor Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Hepatocyte Growth Factor Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Hepatocyte Growth Factor Price Trends (2016-2027)
2 Hepatocyte Growth Factor Estimates and Forecasts by Region
2.1 Global Hepatocyte Growth Factor Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Hepatocyte Growth Factor Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Hepatocyte Growth Factor Sales Market Share by Region (2016-2021)
2.2.2 Global Hepatocyte Growth Factor Revenue Market Share by Region (2016-2021)
2.3 Global Hepatocyte Growth Factor Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Hepatocyte Growth Factor Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Hepatocyte Growth Factor Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Hepatocyte Growth Factor Estimates and Projections (2016-2027)
2.4.2 Europe Hepatocyte Growth Factor Estimates and Projections (2016-2027)
2.4.3 China Hepatocyte Growth Factor Estimates and Projections (2016-2027)
2.4.4 Japan Hepatocyte Growth Factor Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Hepatocyte Growth Factor Estimates and Projections (2016-2027)
2.4.6 India Hepatocyte Growth Factor Estimates and Projections (2016-2027)
3 Global Hepatocyte Growth Factor Competition Landscape by Players
3.1 Global Top Hepatocyte Growth Factor Players by Sales (2016-2021)
3.2 Global Top Hepatocyte Growth Factor Players by Revenue (2016-2021)
3.3 Global Hepatocyte Growth Factor Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hepatocyte Growth Factor as of 2020)
3.4 Global Hepatocyte Growth Factor Average Price by Company (2016-2021)
3.5 Manufacturers Hepatocyte Growth Factor Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Hepatocyte Growth Factor Market Size by Type
4.1 Global Hepatocyte Growth Factor Historic Market Review by Type (2016-2021)
4.1.1 Global Hepatocyte Growth Factor Sales Market Share by Type (2016-2021)
4.1.2 Global Hepatocyte Growth Factor Revenue Market Share by Type (2016-2021)
4.1.3 Global Hepatocyte Growth Factor Price by Type (2016-2021)
4.2 Global Hepatocyte Growth Factor Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Hepatocyte Growth Factor Sales Forecast by Type (2022-2027)
4.2.2 Global Hepatocyte Growth Factor Revenue Forecast by Type (2022-2027)
4.2.3 Global Hepatocyte Growth Factor Price Forecast by Type (2022-2027)
5 Global Hepatocyte Growth Factor Market Size by Application
5.1 Global Hepatocyte Growth Factor Historic Market Review by Application (2016-2021)
5.1.1 Global Hepatocyte Growth Factor Sales Market Share by Application (2016-2021)
5.1.2 Global Hepatocyte Growth Factor Revenue Market Share by Application (2016-2021)
5.1.3 Global Hepatocyte Growth Factor Price by Application (2016-2021)
5.2 Global Hepatocyte Growth Factor Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Hepatocyte Growth Factor Sales Forecast by Application (2022-2027)
5.2.2 Global Hepatocyte Growth Factor Revenue Forecast by Application (2022-2027)
5.2.3 Global Hepatocyte Growth Factor Price Forecast by Application (2022-2027)
6 North America Hepatocyte Growth Factor Market Facts & Figures
6.1 North America Hepatocyte Growth Factor Sales by Company
6.1.1 North America Hepatocyte Growth Factor Sales by Company (2016-2021)
6.1.2 North America Hepatocyte Growth Factor Revenue by Company (2016-2021)
6.2 North America Hepatocyte Growth Factor Sales Breakdown by Type
6.2.1 North America Hepatocyte Growth Factor Sales Breakdown by Type (2016-2021)
6.2.2 North America Hepatocyte Growth Factor Sales Breakdown by Type (2022-2027)
6.3 North America Hepatocyte Growth Factor Sales Breakdown by Application
6.3.1 North America Hepatocyte Growth Factor Sales Breakdown by Application (2016-2021)
6.3.2 North America Hepatocyte Growth Factor Sales Breakdown by Application (2022-2027)
7 Europe Hepatocyte Growth Factor Market Facts & Figures
7.1 Europe Hepatocyte Growth Factor Sales by Company
7.1.1 Europe Hepatocyte Growth Factor Sales by Company (2016-2021)
7.1.2 Europe Hepatocyte Growth Factor Revenue by Company (2016-2021)
7.2 Europe Hepatocyte Growth Factor Sales Breakdown by Type
7.2.1 Europe Hepatocyte Growth Factor Sales Breakdown by Type (2016-2021)
7.2.2 Europe Hepatocyte Growth Factor Sales Breakdown by Type (2022-2027)
7.3 Europe Hepatocyte Growth Factor Sales Breakdown by Application
7.3.1 Europe 135 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 135 Sales Breakdown by Application (2022-2027)
8 China Hepatocyte Growth Factor Market Facts & Figures
8.1 China Hepatocyte Growth Factor Sales by Company
8.1.1 China Hepatocyte Growth Factor Sales by Company (2016-2021)
8.1.2 China Hepatocyte Growth Factor Revenue by Company (2016-2021)
8.2 China Hepatocyte Growth Factor Sales Breakdown by Type
8.2.1 China Hepatocyte Growth Factor Sales Breakdown by Type (2016-2021)
8.2.2 China Hepatocyte Growth Factor Sales Breakdown by Type (2022-2027)
8.3 China Hepatocyte Growth Factor Sales Breakdown by Application
8.3.1 China 243 Sales Breakdown by Application (2016-2021)
8.3.2 China 243 Sales Breakdown by Application (2022-2027)
9 Japan Hepatocyte Growth Factor Market Facts & Figures
9.1 Japan Hepatocyte Growth Factor Sales by Company
9.1.1 Japan Hepatocyte Growth Factor Sales by Company (2016-2021)
9.1.2 Japan Hepatocyte Growth Factor Revenue by Company (2016-2021)
9.2 Japan Hepatocyte Growth Factor Sales Breakdown by Type
9.2.1 Japan Hepatocyte Growth Factor Sales Breakdown by Type (2016-2021)
9.2.2 Japan Hepatocyte Growth Factor Sales Breakdown by Type (2022-2027)
9.3 Japan Hepatocyte Growth Factor Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Hepatocyte Growth Factor Market Facts & Figures
10.1 Southeast Asia Hepatocyte Growth Factor Sales by Company
10.1.1 Southeast Asia Hepatocyte Growth Factor Sales by Company (2016-2021)
10.1.2 Southeast Asia Hepatocyte Growth Factor Revenue by Company (2016-2021)
10.2 Southeast Asia Hepatocyte Growth Factor Sales Breakdown by Type
10.2.1 Southeast Asia Hepatocyte Growth Factor Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Hepatocyte Growth Factor Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Hepatocyte Growth Factor Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Hepatocyte Growth Factor Market Facts & Figures
11.1 India Hepatocyte Growth Factor Sales by Company
11.1.1 India Hepatocyte Growth Factor Sales by Company (2016-2021)
11.1.2 India Hepatocyte Growth Factor Revenue by Company (2016-2021)
11.2 India Hepatocyte Growth Factor Sales Breakdown by Type
11.2.1 India Hepatocyte Growth Factor Sales Breakdown by Type (2016-2021)
11.2.2 India Hepatocyte Growth Factor Sales Breakdown by Type (2022-2027)
11.3 India Hepatocyte Growth Factor Sales Breakdown by Application
11.3.1 India Hepatocyte Growth Factor Sales Breakdown by Application (2016-2021)
11.3.2 India Hepatocyte Growth Factor Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Hepatocyte Growth Factor Business
12.1 ViroMed
12.1.1 ViroMed Corporation Information
12.1.2 ViroMed Business Overview
12.1.3 ViroMed Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2016-2021)
12.1.4 ViroMed Hepatocyte Growth Factor Products Offered
12.1.5 ViroMed Recent Development
12.2 AnGes MG
12.2.1 AnGes MG Corporation Information
12.2.2 AnGes MG Business Overview
12.2.3 AnGes MG Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2016-2021)
12.2.4 AnGes MG Hepatocyte Growth Factor Products Offered
12.2.5 AnGes MG Recent Development
12.3 M3 Biotechnology
12.3.1 M3 Biotechnology Corporation Information
12.3.2 M3 Biotechnology Business Overview
12.3.3 M3 Biotechnology Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2016-2021)
12.3.4 M3 Biotechnology Hepatocyte Growth Factor Products Offered
12.3.5 M3 Biotechnology Recent Development
12.4 AVEO Pharmaceuticals
12.4.1 AVEO Pharmaceuticals Corporation Information
12.4.2 AVEO Pharmaceuticals Business Overview
12.4.3 AVEO Pharmaceuticals Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2016-2021)
12.4.4 AVEO Pharmaceuticals Hepatocyte Growth Factor Products Offered
12.4.5 AVEO Pharmaceuticals Recent Development
12.5 Molecular Partners
12.5.1 Molecular Partners Corporation Information
12.5.2 Molecular Partners Business Overview
12.5.3 Molecular Partners Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Molecular Partners Hepatocyte Growth Factor Products Offered
12.5.5 Molecular Partners Recent Development
12.6 Yooyoung Pharm
12.6.1 Yooyoung Pharm Corporation Information
12.6.2 Yooyoung Pharm Business Overview
12.6.3 Yooyoung Pharm Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Yooyoung Pharm Hepatocyte Growth Factor Products Offered
12.6.5 Yooyoung Pharm Recent Development
12.7 F-star
12.7.1 F-star Corporation Information
12.7.2 F-star Business Overview
12.7.3 F-star Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2016-2021)
12.7.4 F-star Hepatocyte Growth Factor Products Offered
12.7.5 F-star Recent Development
12.8 Galaxy Biotech
12.8.1 Galaxy Biotech Corporation Information
12.8.2 Galaxy Biotech Business Overview
12.8.3 Galaxy Biotech Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Galaxy Biotech Hepatocyte Growth Factor Products Offered
12.8.5 Galaxy Biotech Recent Development
12.9 Kringle Pharma
12.9.1 Kringle Pharma Corporation Information
12.9.2 Kringle Pharma Business Overview
12.9.3 Kringle Pharma Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Kringle Pharma Hepatocyte Growth Factor Products Offered
12.9.5 Kringle Pharma Recent Development
13 Hepatocyte Growth Factor Manufacturing Cost Analysis
13.1 Hepatocyte Growth Factor Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Hepatocyte Growth Factor
13.4 Hepatocyte Growth Factor Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Hepatocyte Growth Factor Distributors List
14.3 Hepatocyte Growth Factor Customers
15 Market Dynamics
15.1 Hepatocyte Growth Factor Market Trends
15.2 Hepatocyte Growth Factor Drivers
15.3 Hepatocyte Growth Factor Market Challenges
15.4 Hepatocyte Growth Factor Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Hepatocyte Growth Factor Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Hepatocyte Growth Factor Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Hepatocyte Growth Factor Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Hepatocyte Growth Factor Sales (K Units) by Region (2016-2021)
Table 5. Global Hepatocyte Growth Factor Sales Market Share by Region (2016-2021)
Table 6. Global Hepatocyte Growth Factor Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Hepatocyte Growth Factor Revenue Share by Region (2016-2021)
Table 8. Global Hepatocyte Growth Factor Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Hepatocyte Growth Factor Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Hepatocyte Growth Factor Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Hepatocyte Growth Factor Revenue Share Forecast by Region (2022-2027)
Table 12. Global Hepatocyte Growth Factor Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Hepatocyte Growth Factor Sales Share by Company (2016-2021)
Table 14. Global Hepatocyte Growth Factor Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Hepatocyte Growth Factor Revenue Share by Company (2016-2021)
Table 16. Global Hepatocyte Growth Factor by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatocyte Growth Factor as of 2020)
Table 17. Global Hepatocyte Growth Factor Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Hepatocyte Growth Factor Manufacturing Sites and Area Served
Table 19. Manufacturers Hepatocyte Growth Factor Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Hepatocyte Growth Factor Sales (K Units) by Type (2016-2021)
Table 22. Global Hepatocyte Growth Factor Sales Share by Type (2016-2021)
Table 23. Global Hepatocyte Growth Factor Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Hepatocyte Growth Factor Price (USD/Unit) by Type (2016-2021)
Table 25. Global Hepatocyte Growth Factor Sales Share by Type (2022-2027)
Table 26. Global Hepatocyte Growth Factor Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Hepatocyte Growth Factor Revenue Share by Type (2022-2027)
Table 28. Global Hepatocyte Growth Factor Price (USD/Unit) by Type (2022-2027)
Table 29. Global Hepatocyte Growth Factor Sales (K Units) by Application (2016-2021)
Table 30. Global Hepatocyte Growth Factor Sales Share by Application (2016-2021)
Table 31. Global Hepatocyte Growth Factor Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Hepatocyte Growth Factor Price (USD/Unit) by Application (2016-2021)
Table 33. Global Hepatocyte Growth Factor Sales (K Units) by Application (2022-2027)
Table 34. Global Hepatocyte Growth Factor Sales Share by Application (2022-2027)
Table 35. Global Hepatocyte Growth Factor Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Hepatocyte Growth Factor Revenue Share by Application (2022-2027)
Table 37. Global Hepatocyte Growth Factor Price (USD/Unit) by Application (2022-2027)
Table 38. North America Hepatocyte Growth Factor Sales (K Units) by Company (2016-2021)
Table 39. North America Hepatocyte Growth Factor Sales Market Share by Company (2016-2021)
Table 40. North America Hepatocyte Growth Factor Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Hepatocyte Growth Factor Revenue Market Share by Company (2016-2021)
Table 42. North America Hepatocyte Growth Factor Sales by Type (2016-2021) & (K Units)
Table 43. North America Hepatocyte Growth Factor Sales Market Share by Type (2016-2021)
Table 44. North America Hepatocyte Growth Factor Sales by Type (2022-2027) & (K Units)
Table 45. North America Hepatocyte Growth Factor Sales Market Share by Type (2022-2027)
Table 46. North America Hepatocyte Growth Factor Sales by Application (2016-2021) & (K Units)
Table 47. North America Hepatocyte Growth Factor Sales Market Share by Application (2016-2021)
Table 48. North America Hepatocyte Growth Factor Sales by Application (2022-2027) & (K Units)
Table 49. North America Hepatocyte Growth Factor Sales Market Share by Application (2022-2027)
Table 50. Europe Hepatocyte Growth Factor Sales (K Units) by Company (2016-2021)
Table 51. Europe Hepatocyte Growth Factor Sales Market Share by Company (2016-2021)
Table 52. Europe Hepatocyte Growth Factor Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Hepatocyte Growth Factor Revenue Market Share by Company (2016-2021)
Table 54. Europe Hepatocyte Growth Factor Sales by Type (2016-2021) & (K Units)
Table 55. Europe Hepatocyte Growth Factor Sales Market Share by Type (2016-2021)
Table 56. Europe Hepatocyte Growth Factor Sales by Type (2022-2027) & (K Units)
Table 57. Europe Hepatocyte Growth Factor Sales Market Share by Type (2022-2027)
Table 58. Europe Hepatocyte Growth Factor Sales by Application (2016-2021) & (K Units)
Table 59. Europe Hepatocyte Growth Factor Sales Market Share by Application (2016-2021)
Table 60. Europe Hepatocyte Growth Factor Sales by Application (2022-2027) & (K Units)
Table 61. Europe Hepatocyte Growth Factor Sales Market Share by Application (2022-2027)
Table 62. China Hepatocyte Growth Factor Sales (K Units) by Company (2016-2021)
Table 63. China Hepatocyte Growth Factor Sales Market Share by Company (2016-2021)
Table 64. China Hepatocyte Growth Factor Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Hepatocyte Growth Factor Revenue Market Share by Company (2016-2021)
Table 66. China Hepatocyte Growth Factor Sales by Type (2016-2021) & (K Units)
Table 67. China Hepatocyte Growth Factor Sales Market Share by Type (2016-2021)
Table 68. China Hepatocyte Growth Factor Sales by Type (2022-2027) & (K Units)
Table 69. China Hepatocyte Growth Factor Sales Market Share by Type (2022-2027)
Table 70. China Hepatocyte Growth Factor Sales by Application (2016-2021) & (K Units)
Table 71. China Hepatocyte Growth Factor Sales Market Share by Application (2016-2021)
Table 72. China Hepatocyte Growth Factor Sales by Application (2022-2027) & (K Units)
Table 73. China Hepatocyte Growth Factor Sales Market Share by Application (2022-2027)
Table 74. Japan Hepatocyte Growth Factor Sales (K Units) by Company (2016-2021)
Table 75. Japan Hepatocyte Growth Factor Sales Market Share by Company (2016-2021)
Table 76. Japan Hepatocyte Growth Factor Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Hepatocyte Growth Factor Revenue Market Share by Company (2016-2021)
Table 78. Japan Hepatocyte Growth Factor Sales by Type (2016-2021) & (K Units)
Table 79. Japan Hepatocyte Growth Factor Sales Market Share by Type (2016-2021)
Table 80. Japan Hepatocyte Growth Factor Sales by Type (2022-2027) & (K Units)
Table 81. Japan Hepatocyte Growth Factor Sales Market Share by Type (2022-2027)
Table 82. Japan Hepatocyte Growth Factor Sales by Application (2016-2021) & (K Units)
Table 83. Japan Hepatocyte Growth Factor Sales Market Share by Application (2016-2021)
Table 84. Japan Hepatocyte Growth Factor Sales by Application (2022-2027) & (K Units)
Table 85. Japan Hepatocyte Growth Factor Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Hepatocyte Growth Factor Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Hepatocyte Growth Factor Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Hepatocyte Growth Factor Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Hepatocyte Growth Factor Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Hepatocyte Growth Factor Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Hepatocyte Growth Factor Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Hepatocyte Growth Factor Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Hepatocyte Growth Factor Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Hepatocyte Growth Factor Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Hepatocyte Growth Factor Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Hepatocyte Growth Factor Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Hepatocyte Growth Factor Sales Market Share by Application (2022-2027)
Table 98. India Hepatocyte Growth Factor Sales (K Units) by Company (2016-2021)
Table 99. India Hepatocyte Growth Factor Sales Market Share by Company (2016-2021)
Table 100. India Hepatocyte Growth Factor Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Hepatocyte Growth Factor Revenue Market Share by Company (2016-2021)
Table 102. India Hepatocyte Growth Factor Sales by Type (2016-2021) & (K Units)
Table 103. India Hepatocyte Growth Factor Sales Market Share by Type (2016-2021)
Table 104. India Hepatocyte Growth Factor Sales by Type (2022-2027) & (K Units)
Table 105. India Hepatocyte Growth Factor Sales Market Share by Type (2022-2027)
Table 106. India Hepatocyte Growth Factor Sales by Application (2016-2021) & (K Units)
Table 107. India Hepatocyte Growth Factor Sales Market Share by Application (2016-2021)
Table 108. India Hepatocyte Growth Factor Sales by Application (2022-2027) & (K Units)
Table 109. India Hepatocyte Growth Factor Sales Market Share by Application (2022-2027)
Table 110. ViroMed Corporation Information
Table 111. ViroMed Description and Business Overview
Table 112. ViroMed Hepatocyte Growth Factor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. ViroMed Hepatocyte Growth Factor Product
Table 114. ViroMed Recent Development
Table 115. AnGes MG Corporation Information
Table 116. AnGes MG Description and Business Overview
Table 117. AnGes MG Hepatocyte Growth Factor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. AnGes MG Hepatocyte Growth Factor Product
Table 119. AnGes MG Recent Development
Table 120. M3 Biotechnology Corporation Information
Table 121. M3 Biotechnology Description and Business Overview
Table 122. M3 Biotechnology Hepatocyte Growth Factor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. M3 Biotechnology Hepatocyte Growth Factor Product
Table 124. M3 Biotechnology Recent Development
Table 125. AVEO Pharmaceuticals Corporation Information
Table 126. AVEO Pharmaceuticals Description and Business Overview
Table 127. AVEO Pharmaceuticals Hepatocyte Growth Factor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. AVEO Pharmaceuticals Hepatocyte Growth Factor Product
Table 129. AVEO Pharmaceuticals Recent Development
Table 130. Molecular Partners Corporation Information
Table 131. Molecular Partners Description and Business Overview
Table 132. Molecular Partners Hepatocyte Growth Factor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Molecular Partners Hepatocyte Growth Factor Product
Table 134. Molecular Partners Recent Development
Table 135. Yooyoung Pharm Corporation Information
Table 136. Yooyoung Pharm Description and Business Overview
Table 137. Yooyoung Pharm Hepatocyte Growth Factor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Yooyoung Pharm Hepatocyte Growth Factor Product
Table 139. Yooyoung Pharm Recent Development
Table 140. F-star Corporation Information
Table 141. F-star Description and Business Overview
Table 142. F-star Hepatocyte Growth Factor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. F-star Hepatocyte Growth Factor Product
Table 144. F-star Recent Development
Table 145. Galaxy Biotech Corporation Information
Table 146. Galaxy Biotech Hepatocyte Growth Factor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Galaxy Biotech Description and Business Overview
Table 148. Galaxy Biotech Hepatocyte Growth Factor Product
Table 149. Galaxy Biotech Recent Development
Table 150. Kringle Pharma Corporation Information
Table 151. Kringle Pharma Hepatocyte Growth Factor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Kringle Pharma Description and Business Overview
Table 153. Kringle Pharma Hepatocyte Growth Factor Product
Table 154. Kringle Pharma Recent Development
Table 155. Production Base and Market Concentration Rate of Raw Material
Table 156. Key Suppliers of Raw Materials
Table 157. Hepatocyte Growth Factor Distributors List
Table 158. Hepatocyte Growth Factor Customers List
Table 159. Hepatocyte Growth Factor Market Trends
Table 160. Hepatocyte Growth Factor Market Drivers
Table 161. Hepatocyte Growth Factor Market Challenges
Table 162. Hepatocyte Growth Factor Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Hepatocyte Growth Factor Product Picture
Figure 2. Global Hepatocyte Growth Factor Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Hepatocyte Growth Factor Sales Market Share by Application in 2021 & 2027
Figure 6. Oncology Examples
Figure 7. Cardiovascular Examples
Figure 8. Central Nervous System Examples
Figure 9. Hematological Disorders Examples
Figure 10. Others Examples
Figure 11. Global Hepatocyte Growth Factor Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Hepatocyte Growth Factor Sales Growth Rate (2016-2027) & (US$ Million)
Figure 13. Global Hepatocyte Growth Factor Sales (K Units) Growth Rate (2016-2027)
Figure 14. Global Hepatocyte Growth Factor Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 15. Global Hepatocyte Growth Factor Revenue Market Share by Region: 2016 VS 2021
Figure 16. Global Hepatocyte Growth Factor Revenue Market Share by Region: 2021 VS 2027
Figure 17. North America Hepatocyte Growth Factor Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. North America Hepatocyte Growth Factor Sales (K Units) Growth Rate (2016-2027)
Figure 19. Europe Hepatocyte Growth Factor Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. Europe Hepatocyte Growth Factor Sales (Million USD) Growth Rate (2016-2027)
Figure 21. China Hepatocyte Growth Factor Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. China Hepatocyte Growth Factor Sales (Million USD) and Growth Rate (2016-2027)
Figure 23. Japan Hepatocyte Growth Factor Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Japan Hepatocyte Growth Factor Sales (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Hepatocyte Growth Factor Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. Southeast Asia Hepatocyte Growth Factor Sales (Million USD) Growth Rate (2016-2027)
Figure 27. India Hepatocyte Growth Factor Revenue (Million USD) Growth Rate (2016-2027)
Figure 28. India Hepatocyte Growth Factor Sales (Million USD) Growth Rate (2016-2027)
Figure 29. Global 5 Largest Hepatocyte Growth Factor Players Market Share by Revenue in Hepatocyte Growth Factor: 2016 & 2020
Figure 30. Hepatocyte Growth Factor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 31. Global Hepatocyte Growth Factor Revenue Share by Type (2016-2021)
Figure 32. Global Hepatocyte Growth Factor Revenue Growth Rate by Type in 2016 & 2020
Figure 33. Global Hepatocyte Growth Factor Revenue Share by Application (2016-2021)
Figure 34. Global Hepatocyte Growth Factor Revenue Growth Rate by Application in 2016 & 2020
Figure 35. North America Hepatocyte Growth Factor Sales Market Share by Type in 2020
Figure 36. North America Hepatocyte Growth Factor Sales Market Share by Application in 2020
Figure 37. Europe Hepatocyte Growth Factor Sales Market Share by Type in 2020
Figure 38. Europe Hepatocyte Growth Factor Sales Market Share by Application in 2020
Figure 39. China Hepatocyte Growth Factor Sales Market Share by Type in 2020
Figure 40. China Hepatocyte Growth Factor Sales Market Share by Application in 2020
Figure 41. Japan Hepatocyte Growth Factor Sales Market Share by Type in 2020
Figure 42. Japan Hepatocyte Growth Factor Sales Market Share by Application in 2020
Figure 43. Southeast Asia Hepatocyte Growth Factor Sales Market Share by Type in 2020
Figure 44. Southeast Asia Hepatocyte Growth Factor Sales Market Share by Application in 2020
Figure 45. India Hepatocyte Growth Factor Sales Market Share by Type in 2020
Figure 46. India Hepatocyte Growth Factor Sales Market Share by Application in 2020
Figure 47. Key Raw Materials Price Trend
Figure 48. Manufacturing Cost Structure of Hepatocyte Growth Factor
Figure 49. Manufacturing Process Analysis of Hepatocyte Growth Factor
Figure 50. Hepatocyte Growth Factor Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
ヒト血液凝固因子VIIのグローバル市場2021 Human Coagulation Factor VII is one of the proteins that cause blood to clot in the coagulation cascade. It is an enzyme of the serine protease class. It is sometimes used unlicensed in severe uncontrollable bleeding, although there have been safety concerns. A bio similar form of recombinant activa…- 世界のNT3成長因子受容体市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global NT 3 Growth Factor Receptor Market The global NT 3 Growth Factor Receptor market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity…
- 世界のトランスフォーミング増殖因子ベータ 2市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Transforming Growth Factor Beta 2 Market The global Transforming Growth Factor Beta 2 market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high da…
- 世界のグリア細胞株由来神経栄養因子市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Glial Cell Line Derived Neurotrophic Factor Market The global Glial Cell Line Derived Neurotrophic Factor market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in …
- 世界の凝固第XI因子市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Coagulation Factor XI Market The global Coagulation Factor XI market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report…